Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 19:11:1205971.
doi: 10.3389/fped.2023.1205971. eCollection 2023.

Prophylactic use of levosimendan in preoperative setting for surgical repair of congenital heart disease in children

L Wannaz  1 , L Boillat  2 , M H Perez  2 , S Di Bernardo  1
Affiliations

Prophylactic use of levosimendan in preoperative setting for surgical repair of congenital heart disease in children

L Wannaz et al. Front Pediatr. .

Abstract

Introduction: Low cardiac output syndrome (LCOS) is a significant cause of morbidity and the leading cause of mortality after pediatric cardiac surgery. Levosimendan has been shown safe and effective in pediatrics to treat LCOS. We aimed to review our local strategy with preoperative prophylactic Levosimendan infusion to minimize LCOS after heart surgery in identified high-risk patients.

Methods: Retrospective monocentric study. As there is no reliable cardiac output measurement in children, we recorded hemodynamic parameters as surrogates of cardiac output after extracorporeal circulation through an electronic patient survey system at different time points.

Results: Seventy-two children received Levosimendan before surgery between 2010 and 2019. As expected, most patients were newborns and infants with prolonged open-heart surgeries. Median cardiopulmonary bypass time was 182 [137-234] min, and aortic clamping time was 95 [64-126] min. The postoperative hemodynamic parameters, vasoactive-inotropic score, and urine output remained stable throughout the first 48 h. Only a tiny portion of the patients had combined surrogate markers of LCOS with a maximal median arterial lactate of 2.6 [1.9-3.5] mmol/L during the first six postoperative hours, which then progressively normalized. The median arterio-venous difference in oxygen saturation was 31 [23-38] % between 12 and 18 h post-surgery and gradually decreased. The median venous-to-arterial CO2 difference was the highest at 10 [7-12] mmHg between 12 and 18 h post-surgery. Nine patients (13%) required extracorporeal membrane oxygenation. No patient required dialysis or hemofiltration. Mortality was 0%.

Conclusion: Before congenital heart surgery, preoperative prophylactic administration of Levosimendan seems effective and safe for decreasing occurrence and duration of LCOS in high-risk children.

Keywords: cardiac surgery; congenital heart disease; intensive care; levosimendan; low cardiac output syndome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Box plot of vasoactive inotropic score and venous-to-arterial O2 saturation difference over time.
Figure 2
Figure 2
Box plot of mean heart rate and maximal arterial blood lactate over time.
Figure 3
Figure 3
Box plot of pressure perfusion and urine output over time.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ma M, Gauvreau K, Allan CK, Mayer JE, Jenkins KJ. Causes of death after congenital heart surgery. Ann Thorac Surg. (2007) 83(4):1438–45. 10.1016/j.athoracsur.2006.10.073 - DOI - PubMed
    1. Shi S, Zhao Z, Liu X, Shu Q, Tan L, Lin R, et al. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest. (2008) 134(4):768–74. 10.1378/chest.07-2573 - DOI - PubMed
    1. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. (2003) 107(7):996–1002. 10.1161/01.CIR.0000051365.81920.28 - DOI - PubMed
    1. Wernovsky G, Wypij D, Jonas RA, Mayer JE, Hanley FL, Hickey PR, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. (1995) 92(8):2226–35. 10.1161/01.CIR.92.8.2226 - DOI - PubMed
    1. Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn. (2004) 31(1):43–59. 10.1023/B:JOPA.0000029488.45177.48 - DOI - PubMed